Ticker
PRPHCompany Name
PROPHASE LABS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 13.58M | $ 6.53M | $ 0 | -48.06% |
3/31/2025 | $ 13.63M | $ 10.87M | $ 0 | -79.79% |
12/31/2024 | $ 16.92M | $ 7.59M | $ 0 | -44.88% |
9/30/2024 | $ 18.38M | $ 4.62M | $ 0 | -25.15% |
6/30/2024 | $ 47.7M | $ 5.82M | $ 0 | -12.21% |
3/31/2024 | $ 96.35M | $ 1.15M | $ 0 | -1.2% |
12/31/2023 | $ 116.75M | $ -4.77M | $ 0 | 4.08% |
9/30/2023 | $ 81.83M | $ -8.66M | $ -2K | 10.59% |
6/30/2023 | $ 103.6M | $ -12.98M | $ -2K | 12.54% |
3/31/2023 | $ 136.26M | $ -14.4M | $ -4.71M | 14.02% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for PROPHASE LABS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ -2.89M ]) / Market Cap [ $ 85.99M ]
(=) Payout Yield [ 3.36% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |